Cytokinetics announces additional aficamten data at hypertrophic cardiomyopathy sessions
CYTK•Cytokinetics said aficamten showed significant reductions in left ventricular mass index and wall thickness after 36 weeks in non-obstructive hypertrophic cardiomyopathy. The data were presented at the Hypertrophic Cardiomyopathy Medical Society scientific sessions held with the American Heart Association scientific sessions.
1. Aficamten data presented
Cytokinetics announced additional aficamten data presented at the Hypertrophic Cardiomyopathy Medical Society scientific sessions held in collaboration with the American Heart Association scientific sessions. Aficamten showed significant reductions in left ventricular mass index and wall thickness after 36 weeks in non-obstructive hypertrophic cardiomyopathy.
